Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BiosPacific is a specialized supplier of critical reagents for the global diagnostic industry, focusing on the development and manufacture of high-quality antibodies and antigens. Founded in 1989 and headquartered in Emeryville, California, the company provides a comprehensive portfolio of reagents used in the creation of immunoassays for clinical diagnostics. Their product range covers essential clinical areas such as cardiac markers, cancer markers, infectious diseases, and drugs of abuse. Since its acquisition by Bio-Techne in 2005, BiosPacific has operated as a key business unit within the Bio-Techne portfolio, serving large-scale diagnostic manufacturers with bulk quantities of validated reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BiosPacific.